RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $770,272 | -56.6% | 91,590 | -35.2% | 0.00% | – |
| Q2 2023 | $1,773,987 | +20.0% | 141,241 | +57.4% | 0.00% | – |
| Q1 2023 | $1,477,771 | +10817.3% | 89,725 | +9803.4% | 0.00% | – |
| Q4 2022 | $13,536 | -77.1% | 906 | -65.6% | 0.00% | – |
| Q3 2022 | $59,000 | +5.4% | 2,633 | -22.1% | 0.00% | – |
| Q2 2022 | $56,000 | -92.2% | 3,381 | -86.0% | 0.00% | – |
| Q1 2022 | $721,000 | -49.8% | 24,094 | -48.5% | 0.00% | – |
| Q4 2021 | $1,437,000 | -9.7% | 46,820 | -7.2% | 0.00% | – |
| Q3 2021 | $1,592,000 | +42.1% | 50,466 | +64.9% | 0.00% | – |
| Q2 2021 | $1,120,000 | +229.4% | 30,599 | +211.6% | 0.00% | – |
| Q1 2021 | $340,000 | -64.7% | 9,820 | -57.7% | 0.00% | – |
| Q4 2020 | $964,000 | -31.4% | 23,206 | -29.7% | 0.00% | – |
| Q3 2020 | $1,406,000 | – | 33,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |